Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

COPE logo
ISSN: 2253-1556

Journal Articles:

- 350 records -

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma

Issdisai N, Kaya M, Hellstrand K, Grauers Wiktorin H, Martner A

ImmunoTargets and Therapy 2026, 15:596703

Published Date: 6 June 2026

Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma

Liu S, Wu J, Liu J, Wu K, Huang Y, Geng S, Wang Y, Weng J, Du X, Lai P

ImmunoTargets and Therapy 2026, 15:605729

Published Date: 28 May 2026

The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management

Bertin L, Caldart F, Barchi A, Seregni N, Pasta A, Calabrese F, Marabotto E, Mari A, Farah A, Sirinic E, Sorge A, Ghisa M, Chahuán J, Savarino V, Savarino EV

ImmunoTargets and Therapy 2026, 15:510865

Published Date: 27 May 2026

Comprehensive Review of Immunotherapy in Colorectal Cancer: From Mechanisms to Nursing Interventions

Zhu Q, Lai Y, Zhao J, Zhang Z, Cui X, Kou M

ImmunoTargets and Therapy 2026, 15:603959

Published Date: 27 May 2026

Identification of Prognostic Clinical Features in Grade 4 Immune-Related Adverse Events: A Triangulation Study

Wu Y, Chen J, Tian S, Lin Z, Li Y, Wang C, Lu Q, Lu L, Zhao Y

ImmunoTargets and Therapy 2026, 15:609130

Published Date: 25 May 2026

Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Glioma

Lian X, Allanson VJ, Rasmussen SV, Chauhan S, Tan GK, Morrow P, Hanson K, Lian EB, Haight AR, Hoshino T, Liu X, Berlow NE, Keller C, Lian Y

ImmunoTargets and Therapy 2026, 15:575767

Published Date: 19 May 2026

A Review of Aryl Hydrocarbon Receptor–Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progression

Han H, Dong Q, Zhang Z, Li S, Zhang H, Wang X, Bai J, Shi L, Fu X, Zheng K, Liang L

ImmunoTargets and Therapy 2026, 15:601152

Published Date: 16 May 2026

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data

Meltzer S, Landmark SS, Šaltytė Benth J, Negård A, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH

ImmunoTargets and Therapy 2026, 15:594176

Published Date: 14 May 2026

Role of Cytokines in Bone Diseases and Their Therapeutic Application

Guha A, Wahi P, Lal G

ImmunoTargets and Therapy 2026, 15:604392

Published Date: 7 May 2026

Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumors

Fountzilas E, Kurzrock R, Nishizaki D, Szabo A, Pabla S, DePietro P, Jensen TJ, Kato S, Tsimberidou AM

ImmunoTargets and Therapy 2026, 15:578703

Published Date: 4 May 2026

B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer

Kielbik A, Bahlinger V, Schürch CM, Barcena ML, Vakhrusheva O, Thomas A, Tsaur I, Heitmann JS, Salih HR, Hagelstein I

ImmunoTargets and Therapy 2026, 15:577364

Published Date: 1 May 2026

RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent Infection

Guan Z, Ao X, Zhou L, Yu C, Zhang Z, Li D

ImmunoTargets and Therapy 2026, 15:568661

Published Date: 27 April 2026

Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort

Mitura-Lesiuk M, Najda P, Rdzanek O, Bogucka J, Różycka K, Dubaj M, Zawitkowska J

ImmunoTargets and Therapy 2026, 15:603087

Published Date: 23 April 2026

Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-β Signaling-Mediated Anti-PD-L1 Response in Bladder Cancer

Liang HQ, Li YJ, Yu JY, Mo QZ, Wei QJ, Liang YQ, Wei FY, Zhang XP, Zhao JW, He YX, Feng XD, Yin BT, Liang XW, Nong RJ, Wang YY, Qin M, Cheng JW

ImmunoTargets and Therapy 2026, 15:583577

Published Date: 14 April 2026

Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Model

Sardela de Miranda F, Babcock RL, Mahecha MF, Gukhool PJ, Boligala GP, Garcia AK, Martinez-Marin D, Oliver AG, Hintelmann T, Furr KL, Bose C, Almodovar S, Singh SP, Pruitt K, Melkus MW, Layeequr Rahman R

ImmunoTargets and Therapy 2026, 15:581990

Published Date: 7 April 2026

Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Management

Freiha J, Min YG, Osman C, Rajabally YA

ImmunoTargets and Therapy 2026, 15:390161

Published Date: 2 April 2026

Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphoma

Rohde M, Singh VK, Wolfermann A, Burkhardt B, Blattmann C, Steinbach D, Schneider DT, Ebinger M, Maecker-Kolhoff B, Braun M, Kurch L, Mauz-Körholz C, Körholz D

ImmunoTargets and Therapy 2026, 15:577426

Published Date: 1 April 2026

Comparative Clinical and Electrophysiological Profiles of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes Mellitus: An Observational Study

Al Mamun A, Sumi MSN, Hussain ME, Khan AAM, Rassel MA, Kawnayn G, Yusuf MA, Ranjan R, Moureen A, Adhikary D, Alam MB, Mohammad QD, Karim MN

ImmunoTargets and Therapy 2026, 15:592658

Published Date: 26 March 2026

Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation

Sadanaga T, Jeong HS, Cortez R, Lee JH, Kamle S, Ma B, Shin SJ, Elias JA, Lee CG

ImmunoTargets and Therapy 2026, 15:563951

Published Date: 19 March 2026

The Role of PD-L1 in Lung Cancer: From Biology to Clinical Application

Lamghari H, Karkouri M

ImmunoTargets and Therapy 2026, 15:591588

Published Date: 19 March 2026

NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosis

Kong W, Hu Y, Zhang K, Zhu Z, Zou Y, Teng L, Wang X, Zhang J

ImmunoTargets and Therapy 2026, 15:541852

Published Date: 17 March 2026

The Conjugation of Antibodies to Heat Shock Protein 70 Activates Immune Responses Against Tumor Cells

Khosravi M, Rajaei A, Mohammadian B, Seyfi Abad Shapouri M

ImmunoTargets and Therapy 2026, 15:565942

Published Date: 16 March 2026

Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPID

Gualtiero G, Buso H, Coopmans EC, Milito C, Firinu D, Dalm VA, Cinetto F

ImmunoTargets and Therapy 2026, 15:582718

Published Date: 7 March 2026

Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategies

Cao Z, Tong S, Wang Z, Ji C, Zhang C, Dai X, Wu B

ImmunoTargets and Therapy 2026, 15:581012

Published Date: 5 March 2026

UVB Upregulates Inflammatory Cytokines in Rosacea Cell Model by Promoting the Expression of TRPVs and TLR2

Xie Y, Hu Y, Huang J, Liu J, Zhang Q

ImmunoTargets and Therapy 2026, 15:571037

Published Date: 4 March 2026

Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions

Drzyzga A, Czapla J, Cichoń T, Matuszczak S, Pilny E, Jarosz-Biej M, Ciepła J, Smolarczyk R

ImmunoTargets and Therapy 2026, 15:576457

Published Date: 19 February 2026

The Dual Mechanism of Action of CO-005 Overcomes CD20 Resistance in Diffuse Large B-Cell Lymphoma

Matar S, Skah S, Moltu LE, Åmellem Ø, Hagland HR, Hestdal K, Pettersen RD, Richartz N

ImmunoTargets and Therapy 2026, 15:572396

Published Date: 19 February 2026

Immune Microenvironment of Hair Follicles in Tumor Immunotherapy

Li B, Jiang S, Yang F, Tang M, Lv H, Li L, Chang J

ImmunoTargets and Therapy 2026, 15:554731

Published Date: 16 February 2026

Recent Advances in Vitiligo Treatment

Qiu Y, Su X, Chen J, Jiang S, Tang X, He Y, Liu F

ImmunoTargets and Therapy 2026, 15:577653

Published Date: 11 February 2026

Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)

Stefańczyk SA, Kaiser X, Hagelstein I, Lutz MS, Holzmayer SJ, Zekri L, Märklin M, Jung S

ImmunoTargets and Therapy 2026, 15:533342

Published Date: 10 February 2026

A Novel Prognostic Signature Composed of Autophagy and Liver Metastasis in Colorectal Cancer: Comprehensive Analysis of Bulk and Single-Cell Transcriptomic Data

Bai B, Cui Y, Zhong X, Zhu B, Meng Z, Chen L, Di L, Huang L, Wang J, Jin Z, Lu X, Zhou B

ImmunoTargets and Therapy 2026, 15:563779

Published Date: 6 February 2026

Enhancing Anti-CTLA-4 Antibody Delivery to the Brain Using Focused Ultrasound and Microbubbles

Afonso Pereira M, Drevenakova V, Liu QE, Grewal S, Morse SV

ImmunoTargets and Therapy 2026, 15:569804

Published Date: 2 February 2026

Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer

Gariazzo E, Colamartini F, Ubaldi M, Santo V, Brunetti L, Tomarelli C, Ognissanti D, Nassar J, Costabile S, Romano L, De Vita E, Scorpiniti I, Macrì M, Porreca R, Currà MF, Cortellini A, Ricciuti B, Metro G

ImmunoTargets and Therapy 2026, 15:567238

Published Date: 2 February 2026

Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib

Chen J, Situ Y, Cai J, Liao W, Jiang D, Huang C, Zheng J, Peng L, Lin H

ImmunoTargets and Therapy 2026, 15:569823

Published Date: 22 January 2026

The Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer

Li C, Wang Y, Liang S, Shi H, Mao X, Wang X, Mo D

ImmunoTargets and Therapy 2026, 15:564201

Published Date: 9 January 2026

Identification of Comprehensive Landscape of Peripheral Immunity and Chemokine-Related Genes in Amyotrophic Lateral Sclerosis

Yang X, Huang S, Wang Y, Yuan J, Yao X

ImmunoTargets and Therapy 2026, 15:566733

Published Date: 9 January 2026

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study

Zeng H, Wu Y, Zhang Z, Liu J, Sun J, Liu X, Gu Y, Tian M, Chen W, Shen Z, Shen K, Xu C, Wang X, Tang Z, Sun Y

ImmunoTargets and Therapy 2026, 15:564230

Published Date: 9 January 2026

Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG

Ma T, Liu Y, Zhu Y, Gao Y, Wang X, Liang Y, Wang B, Zhu R

ImmunoTargets and Therapy 2026, 15:559497

Published Date: 8 January 2026

Risk and Management of Bowel Obstruction in Colorectal Cancer Patients Undergoing Immunotherapy: A Cross-Sectional Multicenter Study

Hong ZG, Xiao B, Zheng M, Yang W, Zhu L, Liang G, Luo Y, Tang J, Mei W, Yu JH, Hou Z, Wu X, Ding P, Jiang W

ImmunoTargets and Therapy 2026, 15:563431

Published Date: 6 January 2026

More articles